Single-Oral-Dose Azithromycin Prophylaxis against Experimental Streptococcal or Staphylococcal Aortic Valve Endocarditis

Azithromycin and ampicillin protected 94 and 72% of animals challenged with Streptococcus oralis, respectively (P = 0.177), while azithromycin and vancomycin protected 59 and 94% of the methicillin-resistant Staphylococcus aureus (MRSA)-challenged animals, respectively (P = 0.018). Azithromycin is e...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Tsitsika, Artemis, Pefanis, Angelos, Perdikaris, George S., Donta, Ismini, Karayiannakos, Panayiotis, Giamarellou, Helen
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2000
Assuntos:	Experimental Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89953/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10817749/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.6.1754-1756.2000
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!